荷叶碱对人肝癌细胞株HepG2凋亡及其作用机制

中国药物警戒 ›› 2017, Vol. 14 ›› Issue (12): 715-719.

荷叶碱对人肝癌细胞株HepG2凋亡及其作用机制

李娜,宋金春*

武汉大学人民医院药学部，湖北武汉 430060

收稿日期:2017-07-03 修回日期:2018-01-19 出版日期:2017-12-20 发布日期:2018-01-19
通讯作者: 宋金春，男，博士，主任药师，临床药学。 E-mail：songjc1234@126.com
作者简介:李娜，女，在读硕士，药剂学。

Effects of Nuciferine on Apoptosis of Human Hepatocellular Carcinoma Cell Line HepG2 and Its Mechanism

LI Na ,SONG Jin-chun*

Department of Pharmacy, Renmin Hospital of Wuhan University, Hubei Wuhan 430060, China

Received:2017-07-03 Revised:2018-01-19 Online:2017-12-20 Published:2018-01-19

摘要/Abstract

摘要： 目的研究荷叶碱对人肝癌细胞株HepG2凋亡及其作用机制。方法采用CCK-8法观察荷叶碱对人肝癌细胞株HepG2生长增殖的影响；Hoechst33258染色观察HepG2细胞凋亡形态的变化；流式细胞术检测细胞凋亡率和周期的影响；Western Blot检测HepG2细胞凋亡相关蛋白的表达。结果荷叶碱对体外培养的人肝癌细胞株HepG2的生长具有抑制作用，且呈剂量、时间依赖性；Hoechst 33258染色可见实验组细胞固缩，凋亡小体形成，蓝色荧光加深；流式结果表示，荷叶碱可使HepG2细胞阻滞于G0/G1期，细胞凋亡率随药物浓度的增大亦呈增长趋势；Western Blot结果表明，荷叶碱以浓度梯度抑制NF-КB蛋白，Bcl-2蛋白的表达，促进Bax蛋白的表达。结论荷叶碱可抑制肝癌HepG2细胞的生长增殖，并在一定的范围内呈剂量、时间依赖性。荷叶碱可将人肝癌细胞株HepG2阻滞于G0/G1期，诱导其发生凋亡，凋亡机制可能与调节相关蛋白NF-КB、Bcl-2、Bax的表达有关。

关键词: 荷叶碱, HepG2细胞, 细胞凋亡, NF-КB蛋白, Bcl-2蛋白, Bax蛋白

Abstract: Objective To investigate the effects of nuciferine on apoptosis of human hepatocellular carcinoma cell line HepG2 and its mechanism. Methods The proliferation of nuciferine on HepG2 cells was determined by the assay of cell counting kit-8(CCK-8). The apoptotic morphology of HepG2 cells with Hoechst 33258 staining was observed under fluorescent microscope. Cell cycle distribution and apoptotic rate were evaluated by flow cytomety(FCM). Western Blot analysis was used to detect the protein expression of apoptosis. Results Nuciferine could inhibit the proliferation of human hepatocellular carcinoma cell line HepG2 in a dose and time dependent manner. Hoechst 33258 staining showed that the experimental group of cells shrank, apoptotic bodies formed, blue fluorescence deepened and flow cytometry (FCM) indicated that HepG2 cells were arrested in G0/G1 phase and the apoptotic rate increased with the increase of the concentration of nuciferine. Western Blot result showed that nuciferine inhibited the expression of NF- КB and Bcl-2 proteins while promoted the expression of Bax protein in a concentration-dependent manner. Conclusion Nuciferine could inhibit the growth and proliferation of HepG2 cells in a dose and time-dependent manner and induce the apoptosis of HepG2 cells. Also, HepG2 cells were arrested in G0/G1 phase. Furthermore, up-regulation of Bax protein as well as downregulation of NF-КB and Bcl-2 protein expression may be one of the important apoptotic inducing mechanisms.

Key words: nuciferine, HepG2 cells, apoptosis, NF-КB protein, Bcl-2 protein, Bax protein

中图分类号:

R965

李娜,宋金春. 荷叶碱对人肝癌细胞株HepG2凋亡及其作用机制[J]. 中国药物警戒, 2017, 14(12): 715-719.

LI Na ,SONG Jin-chun. Effects of Nuciferine on Apoptosis of Human Hepatocellular Carcinoma Cell Line HepG2 and Its Mechanism[J]. Chinese Journal of Pharmacovigilance, 2017, 14(12): 715-719.

参考文献

[1] 合理用药国际网络(INRUD)中国中心组临床安全用药组,中国药理学会药源性疾病学专业委员会,中国药学会医院药学专业委员会，等. 中国用药错误管理专家共识[J]. 药物不良反应杂志，2014，16(6):321-326.
[2] Tilyard M, Dovey S, Hall K. Avoiding and fixing medical errors in general practice: prevention strategies reported in the Linnaeus Collaboration's Primary Care International study of medical errors[J]. N Z Med J，2005，118(1208):1264.
[3] Gaur S, Sinha A, Srivastava B. Medication errors in medicine wards in a tertiary care teaching hospital of a hill state in India[J]. A J Pharm and Life Sci，2012，2(1):56-63.
[4] 张亚南，陈宁. 医院药房常见差错隐患的分析及应对措施[J]. 中国药物警戒，2013，10(3):181-183.
[5] 卫生部. 医疗机构药事管理规定[EB/OL] (2011-03-30)[2017-01-18]. http://www.moh.gov.cn/mohyzs/s3585/201103/51113.shtml.
[6] National Coordinating Council for Medication Error Reporting and Prevention. NCC MERP Index for Categorizing Medication Errors [EB/OL] (2001-02-20) [2017-01-18].http://www.nccmerp.org/sites/default/files/indexColor2001-06-12.pdf.
[7] Patel M, Desai M, Shah S, et al. A study of medication errors in a tertiary care hospital[J]. Perspect Clin Res，2016，7(4):168-173.
[8] Mathaiyan J, Jain T, Dubashi B, et al. Prescription, transcription and administration errors in out-patient day care unit of a regional cancer centre in South India[J]. Asian Pac J Cancer Prev，2016，17(5):2611-2617.
[9] 李晓玲，张青霞，王育琴，等. 我国医疗机构用药错误大数据的分析与启示[J]. 药物流行病学杂志，2017，26(1):40-45.
[10] 陈宁, 王婷, 马莉. 345例用药错误原因分析及对策[J]. 中国药物警戒，2015，12(2):106-109.
[11] Berdot S, Sabatier B, Gillaizeau F, et al. Evaluation of drug administration errors in a teaching hospital[J]. BMC Health Services Research，2012，12:60.
[12] Esqué Ruiz M T, Moretones Su ol M G, Rodríguez Miguélez J M, et al. Medication errors in a neonatal unit: One of the main adverse events[J]. An Pediatr (Barc)，2016，84(4):211-217.
[13] Parand A, Garfield S, Vincent C, et al. Carers' medication administration errors in the domiciliary setting: a systematic review[J]. PLoS One，2016，11(12):e0167204.
[14] Keers R N, Williams S D, Cooke J, et al. Causes of medication administration errors in hospitals: a systematic review of quantitative and qualitative evidence[J]. Drug Saf，2013，36:1045-1067.
[15] Sears K, O'Brien-Pallas L, Stevens B, et al. The relationship between nursing experience and education and the occurrence of reported pediatric medication administration errors[J]. J Pediatr Nurs，2016，31(4):283-290.
[16] Winsvold Prang L, Jelsness-J rgensen L P. Should I report? A qualitative study of barriers to incident reporting among nurses working in nursing homes[J]. Geriatr Nurs，2014，35(6):441-447.